A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis

Clinical trial NCT06073847 · RECRUITING

Trial details

NCT number: NCT06073847
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Study type: OBSERVATIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2023-06-13
Primary completion: 2027-12-20
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.